Portal de Periódicos da CAPES

No Robust Evidence of Lumefantrine Resistance

2015; American Society for Microbiology; Volume: 59; Issue: 9 Linguagem: Inglês

10.1128/aac.00329-15

1098-6596

Kamal Hamed, Kelli Kuhen,

Drug-Induced Hepatotoxicity and Protection

Plucinski and colleagues ([1][1]) recently published the results of a therapeutic efficacy study of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in Zaire and Uige Provinces in Angola and concluded that there was evidence of increased lumefantrine resistance in Zaire. It is